Overview

Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension

Status:
Withdrawn
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if dynamic hyperinflation seen in patients with idiopathic pulmonary artery hypertension (iPAH) improves with albuterol therapy.
Phase:
Phase 2
Details
Lead Sponsor:
American Medical Association Foundation
Treatments:
Albuterol